Search filters

List of works by Vicki Seyfert-Margolis

Analysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 Diabetes

article

Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding

scientific article published on 12 July 2007

Community crystal gazing

scientific article

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

scientific article

Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation

scientific article

Erratum: Community crystal gazing

scholarly article published in Nature Biotechnology

Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis

scientific article

International trial of the Edmonton protocol for islet transplantation

scientific article

Marking a path to transplant tolerance

scientific article

Marking a path to transplant tolerance

Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.

scientific article

Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study

scientific article published in 2022

Power enhancement via multivariate outlier testing with gene expression arrays

scientific article published on 16 November 2008

Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays

scientific article published on 28 September 2009

Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer

scientific article published in October 2007

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

scientific article

The evidence gap

scientific article published on 01 March 2018

Tolerance: is it achievable in pediatric solid organ transplantation?

scientific article published on 01 April 2010

Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years

scientific article published on 14 May 2009

Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients

scientific article published on March 2009

When Parallel Roads Meet: Orchestrating Collaborations Between Regulatory, Ethical, and Business Partners in Translational Medicine

scientific article published on 03 May 2019